Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1.
about
Inflammasomes in the Pathophysiology of Kidney DiseasesSecondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damageDendritic cells and macrophages in the kidney: a spectrum of good and evilOsthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathwayNLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function.Uromodulin triggers IL-1β-dependent innate immunity via the NLRP3 inflammasomeThe emerging role of the inflammasome in kidney diseasesActivation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation.Megalin/Cubulin-Lysosome-mediated Albumin Reabsorption Is Involved in the Tubular Cell Activation of NLRP3 Inflammasome and Tubulointerstitial Inflammation.Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GNCalcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretionActivation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.NLRP3 inflammasome mediates contrast media-induced acute kidney injury by regulating cell apoptosis.Caspase-1 Plays a Critical Role in Accelerating Chronic Kidney Disease-Promoted Neointimal Hyperplasia in the Carotid Artery.Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction.Danger control programs cause tissue injury and remodeling.Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis.Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.The NLRP3 inflammasome in kidney disease and autoimmunity.Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury.Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing.Is the inflammasome a potential therapeutic target in renal disease?Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function.Glomerular disease: limiting autoimmune tissue injury: ROS and the inflammasome.ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome.Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury
P2860
Q26740458-654E391B-5205-4074-A5A4-AF013085FB8DQ26770744-958597A5-1878-4499-9147-F7CDAE970CA5Q27023506-9F6AA48E-C42D-4B98-9974-5DD2F5A9BCCAQ28534656-A2A06606-DA50-4BFA-9469-944A9047A296Q34139079-D8D76A52-0EF5-480B-9A1A-BBE231E0CEC5Q34300979-38D23661-AA09-452B-967B-850C25D1D613Q34307043-E3491B0C-4511-47F5-BD2C-7C8D270F2204Q35551778-F6E41AB9-44EF-4A9F-92FB-AA72C7178E20Q35859536-D5B0B064-2F82-45CC-9B31-777026200F4DQ36104809-B0B7014F-6793-4338-B62B-3A700AF3AD4AQ36497205-E9DEDFC7-3624-4B65-B3C9-6FF436F99F0FQ37121306-6BFD1355-ABD4-4EB5-9926-A679058B8001Q37323893-7153D44A-9960-4091-A7FB-5B3F30162A4FQ37461331-DE331995-9459-4F0B-B6EF-DB24472003E5Q37484299-82244BC6-519B-410A-AE04-A9495E5C4F81Q38113929-24A97F80-5FC6-4A26-8AE0-09A54409C75FQ38136506-BDA30879-3EA3-41FD-AB16-385F074F5468Q38692356-7156E1FF-7AE4-4166-9E96-4337EEB0D4BBQ38787339-3E4BE0C4-08D8-4C71-ADF8-B2F554B91F3EQ38925521-5E30C2D3-58A0-41B6-B54C-0FC4BF362066Q38936622-B266BBDD-414D-4097-9852-92D9B7F3755EQ38959449-205C584D-B3CC-4D2E-9491-B5237E198DBDQ39603954-74CABE2D-0E03-423D-8656-E0C5E21770BAQ41934684-C1C1ECA9-DC7C-4E28-AA37-DBCC27ADFBFBQ42362352-B1F3E0B5-49BB-4CE0-9109-D4F30C1ABB2CQ46847412-AA0F3C93-0444-4833-9273-4161E92544C8Q47765187-73EDF6C4-24F4-4A82-B935-91DF2D2DCB00Q55411801-1490B890-39E6-44C3-A908-DB3C0E7DA719Q58700285-5A04BFED-C57A-439A-9069-BFD10C4252C5
P2860
Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@ast
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@en
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@nl
type
label
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@ast
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@en
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@nl
prefLabel
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@ast
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@en
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@nl
P2093
P2860
P1433
P1476
Anti-GBM glomerulonephritis in ...... iated activation of caspase-1.
@en
P2093
Clemens D Cohen
Dan Muruve
Julia Lichtnekert
Khader Valli Rupanagudi
Maja T Lindenmeyer
Onkar P Kulkarni
Shrikant R Mulay
Volker Vielhauer
P2860
P304
P356
10.1371/JOURNAL.PONE.0026778
P407
P577
2011-10-27T00:00:00Z